Anatomic response of occult choroidal neovascularization to intravitreal ranibizumab: A study by indocyanine green angiography

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 250, Issue 4, 2012, Pages 479-484

  Querques, Giuseppe ^a,c   Tran, Thi Ha Chau ^b   Forte, Raimondo ^a   Querques, Lea ^a   Bandello, Francesco ^c   Souied, Eric H ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Fluorescein angiography; Indocyanine angiography; Optical coherence tomography; Ranibizumab

Indexed keywords

RANIBIZUMAB; ANGIOGENESIS INHIBITOR; COLORING AGENT; DIAGNOSTIC AGENT; INDOCYANINE GREEN; MONOCLONAL ANTIBODY;

AGED; ARTICLE; CENTRAL MACULAR THICKNESS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; IMAGE DISPLAY; INDOCYANINE GREEN ANGIOGRAPHY; MALE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS; FLUORESCENCE ANGIOGRAPHY; INTRAVITREAL DRUG ADMINISTRATION; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROIDAL NEOVASCULARIZATION; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; INTRAVITREAL INJECTIONS; MALE; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84861311253     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-011-1831-5     Document Type: Article

References (27)

1. Bressler NM (2004) Age-related macular degeneration is the leading cause of blindness. JAMA 291:1900-1901
2. Gass JD (1994) Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol 118:285-298
3. Macular Photocoagulation Study Group (1991) Laser photocoagulation of subfoveal neovascular lesion in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 109:1220-1231
4. Macular Photocoagulation Study Group (1996). Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Arch Ophthalmol 114:400-412
5. Lafaut BA, Bartz-Schmidt KU, Vanden Broecke C, Aisenbrey S, De Laey JJ, Heimann K (2000) Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularization. Br J Ophthalmol 84:239-243
6. Hermans P, Lommatzsch A, Bomfeld N, Pauleikhoff D (2003) Angiographichistological correlation of late exudative age-related macular degeneration. Ophthalmologe 100:378-383
7. Submacular Surgery Trials Research Group (2006). Comparison of 2D reconstructions of surgically excised subfoveal choroidal neovascularization with fluorescein angiographic features: SST report No. 15. Ophthalmology 113:279e1-279e5
8. Flower RW, Yannuzzi LA, Slakter JS (1997) History of indocyanine green angiography. In: Yannuzzi LA, Flower RW, Slakter JS (eds) History of indocyanine green angiography. Mosby, St Louis, pp 2-17
9. Hayashi K, de Laey JJ (1985) Indocyanine green angiography of submacular choroidal vessels in the human eye. Ophthalmologica 190:20-29
10. Hayashi K, de Laey JJ (1985) Indocyanine green angiography of choroidal neovascular membranes. Ophthalmologica 190:30-39 11.
11. Destro M, Puliafito CA (1989) Indocyanine green videoangiography of choroidal neovascularization. Ophthalmology 96:846-853
12. Guyer DR, Puliafito CA, Mones JM, Friedman E, Chang W, Verdooner SR (1992) Digital indocyanine-green angiography in chorioretinal disorders. Ophthalmology 99:287-291
13. Yannuzzi LA, Slakter JS, Sorenson JA, Guyer DR, Orlock DA (1992) Digital indocyanine green videoangiography and choroidal neovascularization. Retina 12:191-223
14. Sorenson JA, Yannuzzi LA, Slakter JS, Guyer DR, Ho AC, Orlock DA (1994) A pilot study of digital indocyanine green videoangiography for recurrent occult choroidal neovascularization in age-related macular degeneration. Arch Ophthalmol 112:473-479
15. Slakter JS, Yannuzzi LA, Sorenson JA, Guyer DR, Ho AC, Orlock DA (1994) A pilot study of indocyanine green videoangiography-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Arch Ophthalmol 112:465-472
16. Yannuzzi LA, Hope-Ross M, Slakter JS, Guyer DR, Sorenson JA, Ho AC, Sperber DE, Freund KB, Orlock DA (1994) Analysis of vascularized pigment epithelial detachments using indocyanine green videoangiography. Retina 14:99-113
17. Chen Y, Wiesmann C, Fuh G, Li B, Christinger HW, McKay P, de Vos AM, Lowman HB (1999) Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinitymatured Fab in complex with antigen. J Mol Biol 293:865-881
18. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY; MARINA Study Group (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419-1431
19. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S; ANCHOR Study Group (2006) Ranibizumab vs verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432-1444
20. Querques G, Azrya S, Martinelli D, Berboucha E, Feldman A, Pece A, Coscas G, Soubrane G, Souied EH (2010) Ranibizumab for exudative age-related macular degeneration: 24-month outcomes from a single-centre institutional setting. Br J Ophthalmol 94:292-296
21. Regillo CD, Brown DM, Abraham P, Yue H, Ianchulev T, Schneider S, Shams N (2008) Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. Am J Ophthalmol 145:239-248
22. Kaiser PK, Blodi PA, Shapiro H, Acharya NR, MARINA Study Group (2007) Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular agerelated macular degeneration. Ophthalmology 114:1868-1875
23. Keane PA, Liakopoulos S, Ongchin SC, Heussen FM, Msutta S, Chang KT, Walsh AC, Sadda SR (2008) Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 49:3115-3120
24. Kiss CG, Geitzenauer W, Simader C, Gregori G, Schmidt-Erfurth U (2009) Evaluation of ranibizumab-induced changes of highresolution optical coherence tomographic retinal morphology and their impact on visual function. Invest Ophthalmol Vis Sci 50:2376-2383
25. Costagliola C, Semeraro F, Cipollone U, Rinaldi M, Della Corte M, Romano MR (2009) Changes in neovascular choroidal morphology after intravitreal bevacizumab injection: prospective trial on 156 eyes throughout 12-month follow-up. Graefes Arch Clin Exp Ophthalmol 247:1031-1037
26. Yoganathan P, Deramo VA, Lai JC, Tibrewala RK, Fastenberg DM (2006) Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degeneration. Retina 26:994-998
27. Jo N, Mailhos C, Ju M, Cheung E, Bradley J, Nishijima K, Robinson GS, Adamis AP, Shima DT (2006) Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endot elial growth factor therapy in multiple models of ocular neovascularization. Am J Pathol 168:2036-2053